Advertisement
Screener

VERACYTE, INC. (VCYT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

3.4 / 5 stars · 67/98 Roast Me

VERACYTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

VERACYTE, INC. (VCYT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 472.98 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-26

  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-12-31 was 133.13K shares, a 22.87% decline year-over-year.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-09-30 was 93.90K shares, a 4.70% decline year-over-year.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-06-30 was 75.47K shares, a 133.07% increase year-over-year.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-03-31 was 55.70K shares, a 65.50% increase year-over-year.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 472.98K shares, a 41.61% decline from fiscal 2024.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 810.02K shares, a 42.06% increase from fiscal 2023.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 570.20K shares, a 46.95% decline from fiscal 2022.
  • VERACYTE, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.07M shares, a 50.72% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2025-12-31472.98K shares
10-K · filed 2026-02-26
2024-12-31810.02K shares
10-K · filed 2025-02-28
2023-12-31570.20K shares
10-K · filed 2024-02-29
2022-12-311.07M shares
10-K · filed 2023-03-01
2021-12-31713.17K shares
10-K · filed 2022-02-28
2020-12-31421.56K shares
10-K · filed 2021-02-22
2019-12-31180.02K shares
10-K · filed 2020-02-25
2018-12-31779.98K shares
10-K · filed 2019-02-25
2017-12-31715.30K shares
10-K · filed 2018-02-27
2016-12-31133.13K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
227.03K shares
derived: sum of 2 quarters · filed 2017-03-01
302.50K shares
derived: sum of 3 quarters · filed 2017-03-01
358.20K shares
10-K · filed 2017-03-01
2016-09-3093.90K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
169.37K shares
derived: sum of 2 quarters · filed 2016-11-03
225.07K shares
10-Q · filed 2016-11-03
397.69K shares
derived: sum of 4 quarters · filed 2016-11-03
2016-06-3075.47K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
131.17K shares
10-Q · filed 2016-08-03
303.79K shares
derived: sum of 3 quarters · filed 2016-08-03
402.32K shares
derived: sum of 4 quarters · filed 2016-08-03
2016-03-3155.70K shares
10-Q · filed 2016-05-05
228.32K shares
derived: sum of 2 quarters · filed 2016-05-05
326.85K shares
derived: sum of 3 quarters · filed 2016-05-05
359.23K shares
derived: sum of 4 quarters · filed 2016-05-05
2015-12-31172.62K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
271.15K shares
derived: sum of 2 quarters · filed 2016-03-14
303.53K shares
derived: sum of 3 quarters · filed 2016-03-14
337.19K shares
10-K · filed 2016-03-14
2015-09-3098.53K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
130.91K shares
derived: sum of 2 quarters · filed 2015-11-05
164.57K shares
10-Q · filed 2015-11-05
212.78K shares
derived: sum of 4 quarters · filed 2015-11-05
2015-06-3032.38K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
66.03K shares
10-Q · filed 2015-08-13
114.25K shares
derived: sum of 3 quarters · filed 2015-08-13
142.42K shares
derived: sum of 4 quarters · filed 2015-08-13
2015-03-3133.66K shares
10-Q · filed 2015-05-15
81.87K shares
derived: sum of 2 quarters · filed 2015-05-15
110.04K shares
derived: sum of 3 quarters · filed 2015-05-15
194.26K shares
derived: sum of 4 quarters · filed 2015-05-15
2014-12-3148.21K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
76.39K shares
derived: sum of 2 quarters · filed 2015-03-25
160.61K shares
derived: sum of 3 quarters · filed 2015-03-25
196.21K shares
10-K · filed 2015-03-25
2014-09-3028.18K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
112.40K shares
derived: sum of 2 quarters · filed 2014-11-13
148.00K shares
10-Q · filed 2014-11-13
-183.52M shares
derived: sum of 4 quarters · filed 2015-03-25
2014-06-3084.22K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
119.82K shares
10-Q · filed 2014-08-14
-183.55M shares
derived: sum of 3 quarters · filed 2015-03-25
2014-03-3135.60K shares
10-Q · filed 2014-05-09
-183.63M shares
derived: sum of 2 quarters · filed 2015-03-25
2013-12-31-183.67M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
185.44K shares
10-K · filed 2015-03-25
2013-09-30183.85M shares
10-Q · filed 2013-11-25
2012-12-3161.27K shares
10-K · filed 2015-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B